for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

财经

New drug approvals hit 21 year high

U.S. drug approvals more than doubled in 2017 over the previous year. Fred Katayama reports on what's behind the acceleration of approvals.

财经

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up